The purpose of this study is to evaluate the efficacy and safety of arginine hydrochloride
combined with trimetazidine hydrochloride tablets in the treatment of patients with
hepatocellular carcinoma.
Phase:
Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Zhengzhou University
Collaborators:
Anyang Tumor Hospital First Affiliated Hospital of Xinjiang Medical University First Affiliated Hospital of Xinxiang Medical University First People's Hospital of Shangqiu Jiaozuo third people's hospital Luoyang Central Hospital Nanyang Central Hospital Pingmei Shenma Medical Group General Hospital